Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor I receptors

Cell Growth and Differentiation

Volumn 9, Issue 11, 1998, Pages 939-947

  Chen, Hongying ^a   Yan, Guo Chen ^a   Gishizky, Mikhail L ^a  

^a SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; HUMAN INSULIN; INSULIN RECEPTOR; INTERLEUKIN 3; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLALANINE; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR; TYROSINE; WORTMANNIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CULTURE; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; HUMAN; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL SURVIVAL; ENZYME ACTIVATION; HUMANS; LIGANDS; MICE; MITOGENS; PHOSPHOPROTEINS; POINT MUTATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 3643085354     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ullrich, A., and Schlessinger, J. Signal transduction by receptors tyrosine kinase activity. Cell, 70: 313-322, 1990.
2. Kahn, C. R. Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes, 43: 1066-1084, 1994.
3. Sepp-Lorenzino, L. Structure and function of the insulin-like growth factor I receptor. Breast Cancer Res. Treat., 47: 235-253, 1998.
4. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C. T. Molecular and cellular aspects of the insulin-like growth factor-1 receptor. Endocr. Rev., 16: 143-163, 1995.
5. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta, 1332: F105-F126, 1997.
6. Federici, M., Porzio, O., Zucaro, L., Fusco, A., Borboni, P., Lauro, D., and Sesti, G. Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Mol. Cell. Endocrinol., 129: 121-126, 1997.
7. Bailyes, E. M., Nave, B. T., Soos, M. A., Orr, S. R., Hayward, A. C., and Siddle, K. Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem. J., 327: 209-215, 1997.
8. Garrouste, F. L., Remacle-Bonnet, M. M., Lehmann, M. M., Marvaldi, J. L., and Pommier, G. J. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells. Endocrinology, 138: 2021-2032, 1997.
9. McClain, D. A., Maegawa, H., Levy, J., Huecksteadt, T., Dull, T. J., Lee, J., Ullrich, A., and Olefsky, J. M. Properties of a human insulin receptor with a COOH-terminal truncation. I. Insulin binding, autophosphorylation, and endocytosis. J. Biol. Chem., 263: 8904-8911, 1988.
10. Surmacz, E., Sell, C., Swantek, J., Kato, H., Roberts, C. T., Jr., LeRoith, D., and Baserga, R. Dissociation of mitogenesis and transforming activity by C terminal truncation of the insulin-like growth factor receptor. Exp. Cell. Res., 218: 370-380, 1995.
11. Hongo, A., D'Ambrosio, C., Miura, M., Morrione, A., and Baserga, R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene, 12: 1231-1238, 1996.
12. Faria, T. N., Blakesley, V. A., Kato, H., Stannard, B., LeRoith, D., and Roberts, C. T., Jr. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function. J. Biol. Chem., 269: 13922-13928, 1994.
13. Rodriguez-Tarduchy, G., Collins, M. K. L., Garcia, I., and Lopez-Rivas, A. Insulin-like growth factor-1 inhibits apoptosis in IL-3 dependent hemopoietic cells. J. Immunol., 149: 535-540, 1992.
14. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor-1 (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
15. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997.
16. Wang, L. M., Myers, M. G., Jr., Sun, X. J., Aaronson, S. A., White, M., and Pierce, J. H. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science (Washington DC), 261: 1591-1594, 1993.
17. Sun, X. J., Wang, L. M., Zhang, Y., Yenush, L., Myers, M. G., Jr., Glasheen, E., Lane, W. S., Pierce, J. H., and White, M. F. Role of IRS-2 in insulin and cytokine signalling. Nature (Lond.), 377: 173-177, 1995.
18. Seely, B. L., Reichart, D. R., Staubs, P. A., Jhun, B. H., Hsu, D., Maegawa, H., Milarski, K. L., Saltiel, A. R., and Olefsky, J. M. Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein. J. Biol. Chem., 270: 19151-19157, 1995.
19. Cortez, D., Stoica, G., Pierce, J. H., and Pendergast, A. M. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene, 13: 2589-2594, 1996.
20. Franke, T. F., Kaplan, D. R., and Cantley, L. C. PI3K: downstream AKTion blocks apoptosis. Cell, 88: 435-437, 1997.
21. Mendez, R., Myers, M. G., Jr., White, M. F., and Rhoads, R. E. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol. Cell. Biol., 16: 2857-2864, 1996.
22. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., and Blattler, W. A. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol., 17: 427-435, 1997.
23. Tartare-Deckert, S., Sawka-Verhelle, D., Murdaca, J., and Van Obberghen, E. Evidence for a differential interaction of SHC and the insulin receptor substrate I (IRS-1) with the insulin-like growth factor-1 receptor in the yeast two hybrid system. J. Biol. Chem., 270: 23456-23460, 1995.
24. Skolnik, E. Y., Lee, C. H., Batzer, A., Vicentini, L. M., Zhou, M., Daly, R., Myers, M. J., Jr., Backer, J. M., Ullrich, A., White, M. F., and et al. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J., 12: 1929-1936, 1993.
25. Creedon, D. J., Johnson, E. M., and Lawrence, J. C. Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J. Biol. Chem., 271: 20713-20718, 1996.
26. Parrizas, M., Saltiel, A. R., and LeRoith, D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem., 272: 154-161, 1997.
27. Alessi, D. R., and Cohen, P. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev., 8: 55-62, 1998.
28. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nugez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science (Washington DC), 278: 687-689, 1997.
29. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91: 231-241, 1997.
30. White, M. F., and Yenush, L. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr. Top. Microbiol. Immunol., 228: 179-208, 1998.
31. Yenush, L., and White, M. F. The IRS-signalling system during insulin and cytokine action. BioEssays, 19: 491-500, 1997.
32. Scheid, M. P., Lauener, R. W., and Duronio, V. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem. J., 372: 159-162, 1995.
33. Ulrich, E., Duwel, A., Kauffmann-Zeh, A., Gilbert, C., Lyon, D., Rudkin, B., Evan, G., and Martin-Zanca, D. Specific TrkA survival signals interfere with different apoptotic pathways. Oncogene, 16: 825-832, 1998.
34. Scheid, M. P., and Duronio, V. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc. Natl. Acad. Sci. USA, 95: 7439-7444, 1998.
35. Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., and Gishizky, M. L. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell, 75: 175-185, 1993.
36. Hill, R. J., Zozulya, S., Lu, Y. L., Hollenbach, P. W., Joyce-Shaikh, B., Bogenberger, J., and Gishizky, M. L. Differentiation induced by the C-Mpl cytokine receptor is blocked by mutant Shc adaptor protein. Cell Growth Differ., 7: 1125-1134, 1996.
37. Gong, J., Traganos, F., and Darzynkiewicz, Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem., 218: 314-319, 1994.
38. Rohlik, Q. T., Adams, D., Kull, F. C., Jr., and Jacobs, S. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem. Biophys. Res. Commun., 149: 276-281, 1987.